Citadel Advisors
OSCR icon

Citadel Advisors’s Oscar Health OSCR Stock Holding History

Citadel Advisors’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121M Buy
4,229,552
+763,190
+22% +$16.4M 0.01% 842
2026
Q1 		$39.8M Buy
3,466,362
+888,339
+34% +$12.5M 0.01% 1572
2025
Q4 		$37M Sell
2,578,023
-1,709,185
-40% -$29.6M 0.01% 1706
2025
Q3 		$81.2M Buy
4,287,208
+2,279,411
+114% +$37.6M 0.01% 997
2025
Q2 		$43M Buy
2,007,797
+527,572
+36% +$7.84M 0.01% 1354
2025
Q1 		$19.4M Buy
1,480,225
+1,051,614
+245% +$15.6M ﹤0.01% 2073
2024
Q4 		$5.76M Sell
428,611
-4,039,637
-90% -$65M ﹤0.01% 3736
2024
Q3 		$94.8M Buy
4,468,248
+3,276,784
+275% +$59M 0.02% 730
2024
Q2 		$18.8M Buy
1,191,464
+442,909
+59% +$8.14M ﹤0.01% 2058
2024
Q1 		$11.1M Sell
748,555
-2,140,718
-74% -$29.3M ﹤0.01% 2809
2023
Q4 		$26.4M Buy
2,889,273
+267,523
+10% +$1.85M 0.01% 1742
2023
Q3 		$14.6M Buy
2,621,750
+1,794,402
+217% +$12.6M ﹤0.01% 2217
2023
Q2 		$6.67M Sell
827,348
-1,142,698
-58% -$8.43M ﹤0.01% 3222
2023
Q1 		$12.9M Buy
1,970,046
+1,939,578
+6,366% +$7.92M ﹤0.01% 2467
2022
Q4 		$75K Sell
30,468
-981,160
-97% -$3.07M ﹤0.01% 11612
2022
Q3 		$5.05M Buy
1,011,628
+866,341
+596% +$5.06M ﹤0.01% 3852
2022
Q2 		$617K Sell
145,287
-9,236
-6% -$58.8K ﹤0.01% 8175
2022
Q1 		$1.54M Sell
154,523
-1,066,487
-87% -$7.93M ﹤0.01% 6666
2021
Q4 		$9.59M Buy
1,221,010
+982,535
+412% +$12.3M ﹤0.01% 3148
2021
Q3 		$4.15M Buy
238,475
+80,698
+51% +$1.37M ﹤0.01% 4664
2021
Q2 		$3.39M Buy
+157,777
New +$3.78M ﹤0.01% 5308

Other funds holding OSCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors's OSCR Position: Q2 2026 in Review

Citadel Advisors increased its Oscar Health (OSCR) stake by 22% in Q2 2026, buying an estimated $16.4M and bringing the position to 4,229,552 shares worth $121M. The position accounts for 0.01% of the portfolio, ranked #842.

Citadel Advisors first reported a position in OSCR in Q2 2021 and has held it in 21 quarters since. 402 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Citadel Advisors held 4,229,552 shares of Oscar Health worth $121M as of Q2 2026.
  • Citadel Advisors bought 763,190 Oscar Health shares in Q2 2026, an estimated $16.4M.
  • Oscar Health made up 0.01% of Citadel Advisors's portfolio in Q2 2026, its #842 holding.
  • Citadel Advisors first reported a position in Oscar Health in Q2 2021 and has held it in 21 quarters since.
  • 402 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.